WHO ICTRP trial
An exploratory study to assess the distribution of 111In-ABY-002 tracer uptake…
EUCTR2007-002530-11-SE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2007-002530-11-SE |
|---|---|
| Public title | An exploratory study to assess the distribution of 111In-ABY-002 tracer uptake for SPECT imaging in subjects with metastatic HER2-positive breast cancer |
| Scientific title | An exploratory study to assess the distribution of 111In-ABY-002 tracer uptake for SPECT imaging in subjects with metastatic HER2-positive breast cancer |
| Primary sponsor | Affibody AB |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Sweden |
| Conditions | Female subjects having metastatic breast cancer with verified HER2 positive status (DAKO's HerceptTest) in the original primary tumor or one of the current metastases. |
| Interventions | Product Name: 111 In-ABY-002 Pharmaceutical Form: Powder for suspension for injection |
| Registration date | May 7, 2007 |
| Secondary IDs | AFB-100 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: